WEST PHARMACEUTICAL SERVICES, INC. (WST)

337.47 -2.49% (-8.62)

Over 1M: -1.0%

2026-08-28
Style
Area Line Line with markers Steps Candlesno open/high/low yet Hollow candlesno open/high/low yet Barsno open/high/low yet

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

340 345 350 355
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 706.5M Q3 '21 — Operating Cash Flow: 190.1M Q3 '21 — Net Income: 175.6M Q4 '21 — Revenue: 730.8M Q4 '21 — Operating Cash Flow: 160.8M Q4 '21 — Net Income: 147.7M Q1 '22 — Revenue: 720M Q1 '22 — Operating Cash Flow: 151.2M Q1 '22 — Net Income: 173.8M Q2 '22 — Revenue: 771.3M Q2 '22 — Operating Cash Flow: 173.1M Q2 '22 — Net Income: 188.5M Q3 '22 — Revenue: 686.9M Q3 '22 — Operating Cash Flow: 168.9M Q3 '22 — Net Income: 120.6M Q4 '22 — Revenue: 708.7M Q4 '22 — Operating Cash Flow: 230.8M Q4 '22 — Net Income: 103M Q1 '23 — Revenue: 716.6M Q1 '23 — Operating Cash Flow: 138.1M Q1 '23 — Net Income: 140M Q2 '23 — Revenue: 753.8M Q2 '23 — Operating Cash Flow: 169.2M Q2 '23 — Net Income: 155.1M Q3 '23 — Revenue: 747.4M Q3 '23 — Operating Cash Flow: 230.1M Q3 '23 — Net Income: 161.3M Q4 '23 — Revenue: 732M Q4 '23 — Operating Cash Flow: 239.1M Q4 '23 — Net Income: 137M Q1 '24 — Revenue: 695.4M Q1 '24 — Operating Cash Flow: 118.2M Q1 '24 — Net Income: 115.3M Q2 '24 — Revenue: 702.1M Q2 '24 — Operating Cash Flow: 165M Q2 '24 — Net Income: 111.3M Q3 '24 — Revenue: 746.9M Q3 '24 — Operating Cash Flow: 180.1M Q3 '24 — Net Income: 136M Q4 '24 — Revenue: 748.8M Q4 '24 — Operating Cash Flow: 190.1M Q4 '24 — Net Income: 130.1M Q1 '25 — Revenue: 698M Q1 '25 — Operating Cash Flow: 129.4M Q1 '25 — Net Income: 89.8M Q2 '25 — Revenue: 766.5M Q2 '25 — Operating Cash Flow: 177.1M Q2 '25 — Net Income: 131.8M Q3 '25 — Revenue: 804.6M Q3 '25 — Operating Cash Flow: 197.2M Q3 '25 — Net Income: 140M Q4 '25 — Revenue: 805M Q4 '25 — Operating Cash Flow: 251.1M Q4 '25 — Net Income: 132.1M Q1 '26 — Revenue: 844.9M Q1 '26 — Operating Cash Flow: 89.9M Q1 '26 — Net Income: 138.8M Q2 '26 — Revenue: 872.3M Q2 '26 — Operating Cash Flow: 124M Q2 '26 — Net Income: 154M 0 200M 400M 600M 800M 1B
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

5.5
SBC / sales 0.98%
Oper. margin 20.5%
OE margin 12.2%
ROIC 19.5%
Accruals -2.4%
ROA 13.9%
ROCE 19.8%
OCF margin 19.9%
ROE 18.9%
FCF margin 13.1%
Gross margin 36.8%
OCF / EBIT 0.97×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.1
RPO / sales 0.016×
Segment HHI 0.69 HHI
RPO growth —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.7
ND/EBITDA —
Cash / Debt 2.1×
Debt / Eq 0.069×
Debt payback 0.0 yr
Payout 11.0%
Quick ratio 2.1×
F-score 7.0 pts
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.3
Sales/sh Y/Y +13.9%
EPS Y/Y +17.4%
Sales Q/Q +13.8%
Div. growth +3.6%
EBIT Y/Y +17.0%
EBIT CAGR -2.1%
EPS CAGR 4Y -5.9%
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.